Hikma Pharmaceuticals (HKMPY) News Today $46.73 -0.64 (-1.35%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period This FTSE 100 stock looks good to me and I’d consider buying it nowSeptember 30, 2024 | uk.finance.yahoo.comPositive Report for Hikma Pharmaceuticals (HIK) from Berenberg BankSeptember 3, 2024 | markets.businessinsider.comHikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention DayAugust 20, 2024 | prnewswire.comKLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 monthsAugust 15, 2024 | prnewswire.comWe Think Hikma Pharmaceuticals' (LON:HIK) Robust Earnings Are ConservativeAugust 15, 2024 | finance.yahoo.comAfter earnings, is the Hikma Pharmaceuticals share price due a bounce?August 8, 2024 | msn.comHikma given shot in the arm by ‘excellent’ double-digit growthAugust 8, 2024 | msn.comHikma Pharmaceuticals Shares Surge on Earnings, Guidance RaiseAugust 8, 2024 | marketwatch.comHikma Pharmaceuticals shares surge on upbeat guidanceAugust 8, 2024 | investing.comWC enters into partnership with Hikma PharmaceuticalsAugust 2, 2024 | wnewsj.comHikma Pharma Extends Recall Of Acetaminophen InjectionJuly 23, 2024 | markets.businessinsider.comHikma Pharmaceuticals rises Monday, outperforms marketJuly 22, 2024 | marketwatch.comHikma Pharmaceuticals rises Wednesday, still underperforms marketJuly 19, 2024 | marketwatch.comHikma Pharmaceuticals rises Friday, outperforms marketJuly 19, 2024 | marketwatch.comWith 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big gunsApril 15, 2024 | finance.yahoo.comHikma shares spike after pharma giant’s profit up 30 per centFebruary 22, 2024 | msn.comHikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facilityFebruary 21, 2024 | prnewswire.comHikma Pharmaceuticals USA Inc.: Hikma announces US launch of COMBOGESIC IVFebruary 5, 2024 | finanznachrichten.deHikma Pharma Launches Pain Relief Injection COMBOGESIC IV In USFebruary 5, 2024 | markets.businessinsider.comHikma announces US launch of COMBOGESIC® IVFebruary 5, 2024 | finance.yahoo.comActiv Surgical Announces Completion of First International Procedure Using Its ActivSight™ Intelligent LightJanuary 22, 2024 | finance.yahoo.comGuardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North AfricaJanuary 8, 2024 | finance.yahoo.comHikma Pharmaceuticals PLC's (LON:HIK) institutional investors lost 5.8% over the past week but have profited from longer-term gainsNovember 6, 2023 | finance.yahoo.comSK Biopharm inks license deal with Hikma's Middle East unitAugust 17, 2023 | msn.comHikma Pharmaceuticals outperforms market despite losses on the dayAugust 15, 2023 | marketwatch.comHikma Pharmaceuticals goes ex dividend tomorrowAugust 8, 2023 | msn.comIs It Worth Considering Hikma Pharmaceuticals PLC (LON:HIK) For Its Upcoming Dividend?August 6, 2023 | finance.yahoo.comHikma Trims Full-Year Revenue Guidance After Advair Diskus DelayJune 27, 2023 | thestreet.comHikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USPJune 15, 2023 | finance.yahoo.comFTSE 100: Ocado at risk, IMI in – how London Stock Exchange is set to reshuffle the indexMay 31, 2023 | uk.finance.yahoo.comHikma Pharmaceuticals rises Friday, still underperforms marketMay 5, 2023 | marketwatch.comHikma Pharmaceuticals rises Wednesday, outperforms marketMay 3, 2023 | marketwatch.comHikma Pharmaceuticals Full Year 2022 Earnings: EPS Misses ExpectationsMarch 19, 2023 | finance.yahoo.comHikma Pharmaceuticals PLC (HIK)February 7, 2023 | uk.investing.comHikma Pharmaceuticals rises Tuesday, outperforms marketJanuary 31, 2023 | marketwatch.comHikma Pharmaceuticals falls Tuesday, underperforms marketJanuary 24, 2023 | marketwatch.comJunshi inks licensing deal with Hikma for toripalimab; FDA filing still under reviewDecember 27, 2022 | msn.comJunshi Biosciences and Hikma Sign Exclusive Licensing Agreement for Cancer Treatment Drug Toripalimab for the Middle East and North Africa RegionDecember 26, 2022 | financialpost.comHikma Pharmaceuticals rises Thursday, outperforms marketDecember 15, 2022 | marketwatch.comHikma Pharmaceuticals PLC (HKMPY)October 9, 2022 | finance.yahoo.comHKMPY.PK - | Stock Price & Latest News | ReutersSeptember 28, 2022 | reuters.comHikma Pharmaceuticals PLC (H5P.F)September 25, 2022 | uk.finance.yahoo.comHikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the USAugust 30, 2022 | finance.yahoo.comHikma Pharmaceuticals (OTC:HKMPY), Analyst Ratings, Price Targets, PredictionsJuly 17, 2022 | benzinga.comDrugmaker Hikma's CEO Olafsson to step downMay 24, 2022 | news.yahoo.comInvestors in Hikma Pharmaceuticals (LON:HIK) have unfortunately lost 26% over the last yearMay 14, 2022 | finance.yahoo.comHikma completes acquisition of CustopharmApril 21, 2022 | finance.yahoo.comHikma gets preliminary approval from FTC to acquire CustopharmApril 20, 2022 | seekingalpha.comHikma confirms FTC preliminary approval for CustopharmApril 20, 2022 | finance.yahoo.comU.S. FTC approves Hikma deal for Custopharm with conditionsApril 19, 2022 | finance.yahoo.com Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPY and its competitors with MarketBeat's FREE daily newsletter. Email Address Ex WH Advisor Who Predicted Biden Leaving Race Makes Startling New Prediction (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now. Click here to see it because it’s a SHOCKER… HKMPY Media Mentions By Week HKMPY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HKMPY News Sentiment▼0.000.46▲Average Medical News Sentiment HKMPY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HKMPY Articles This Week▼00▲HKMPY Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News Today FFNTF News Today ABSCF News Today ACRHF News Today ACRDF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today AVCNF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HKMPY) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HKMPY Stock Alerts